UNLABELLED: One of the greatest challenges in PET/MR imaging is that of accurate MR-based attenuation correction (AC) of the acquired PET data, which must be solved if the PET/MR modality is to reach its full potential. The aim of this study was to investigate the performance of Siemens' most recent version (VB20P) of MR-based AC of head PET data, by comparing it to CT-based AC. METHODS: (18)F-FDG PET data from seven lymphoma and twelve lung cancer patients examined with a Biograph mMR PET/MR system were reconstructed with both CT-based and MR-based AC, avoiding sources of error arising when comparing PET data from different systems. The resulting images were compared quantitatively by measuring changes in mean SUV in ten different brain regions in both hemispheres, as well as the brainstem. In addition, the attenuation maps (μ maps) were compared regarding volume and localization of cranial bone. RESULTS: The UTE μ maps clearly overestimate the amount of bone in the neck, while slightly underestimating the amount of bone in the cranium, and the localization of bone in the cranial region also differ from the CT μ maps. In air/tissue interfaces in the sinuses and ears, the MRAC method struggles to correctly classify the different tissues. The misclassification of tissue is most likely caused by a combination of artefacts and the insufficiency of the UTE method to accurately separate bone. Quantitatively, this results in a combination of overestimation (0.5-3.6 %) and underestimation (2.7-5.2 %) of PET activity throughout the brain, depending on the proximity to the inaccurate regions. CONCLUSIONS: Our results indicate that the performance of the UTE method as implemented in VB20P is close to the theoretical maximum of such an MRAC method in the brain, while it does not perform satisfactorily in the neck or face/nasal area. Further improvement of the UTE MRAC or other available methods for more accurate segmentation of bone should be incorporated.
UNLABELLED: One of the greatest challenges in PET/MR imaging is that of accurate MR-based attenuation correction (AC) of the acquired PET data, which must be solved if the PET/MR modality is to reach its full potential. The aim of this study was to investigate the performance of Siemens' most recent version (VB20P) of MR-based AC of head PET data, by comparing it to CT-based AC. METHODS: (18)F-FDG PET data from seven lymphoma and twelve lung cancerpatients examined with a Biograph mMR PET/MR system were reconstructed with both CT-based and MR-based AC, avoiding sources of error arising when comparing PET data from different systems. The resulting images were compared quantitatively by measuring changes in mean SUV in ten different brain regions in both hemispheres, as well as the brainstem. In addition, the attenuation maps (μ maps) were compared regarding volume and localization of cranial bone. RESULTS: The UTE μ maps clearly overestimate the amount of bone in the neck, while slightly underestimating the amount of bone in the cranium, and the localization of bone in the cranial region also differ from the CT μ maps. In air/tissue interfaces in the sinuses and ears, the MRAC method struggles to correctly classify the different tissues. The misclassification of tissue is most likely caused by a combination of artefacts and the insufficiency of the UTE method to accurately separate bone. Quantitatively, this results in a combination of overestimation (0.5-3.6 %) and underestimation (2.7-5.2 %) of PET activity throughout the brain, depending on the proximity to the inaccurate regions. CONCLUSIONS: Our results indicate that the performance of the UTE method as implemented in VB20P is close to the theoretical maximum of such an MRAC method in the brain, while it does not perform satisfactorily in the neck or face/nasal area. Further improvement of the UTE MRAC or other available methods for more accurate segmentation of bone should be incorporated.
Authors: Linda M Velasquez; Ronald Boellaard; Georgia Kollia; Wendy Hayes; Otto S Hoekstra; Adriaan A Lammertsma; Susan M Galbraith Journal: J Nucl Med Date: 2009-09-16 Impact factor: 10.057
Authors: Vincent Keereman; Yves Fierens; Tom Broux; Yves De Deene; Max Lonneux; Stefaan Vandenberghe Journal: J Nucl Med Date: 2010-05 Impact factor: 10.057
Authors: Ciprian Catana; Andre van der Kouwe; Thomas Benner; Christian J Michel; Michael Hamm; Matthias Fenchel; Bruce Fischl; Bruce Rosen; Matthias Schmand; A Gregory Sorensen Journal: J Nucl Med Date: 2010-09 Impact factor: 10.057
Authors: M C Aznar; R Sersar; J Saabye; C N Ladefoged; F L Andersen; J H Rasmussen; J Löfgren; T Beyer Journal: Eur J Radiol Date: 2014-04-01 Impact factor: 3.528
Authors: Jian W Dong; Ileana O Jelescu; Benjamin Ades-Aron; Dmitry S Novikov; Kent Friedman; James S Babb; Ricardo S Osorio; James E Galvin; Timothy M Shepherd; Els Fieremans Journal: Neurobiol Aging Date: 2020-01-23 Impact factor: 4.673
Authors: Nicolas A Karakatsanis; Ronan Abgral; Maria Giovanna Trivieri; Marc R Dweck; Philip M Robson; Claudia Calcagno; Gilles Boeykens; Max L Senders; Willem J M Mulder; Charalampos Tsoumpas; Zahi A Fayad Journal: J Nucl Cardiol Date: 2019-10-30 Impact factor: 5.952
Authors: Ivo Rausch; Andreas Zitterl; Neydher Berroterán-Infante; Lucas Rischka; Daniela Prayer; Matthias Fenchel; Reza A Sareshgi; Alexander R Haug; Marcus Hacker; Thomas Beyer; Tatjana Traub-Weidinger Journal: Eur Radiol Date: 2019-01-11 Impact factor: 5.315
Authors: Philip M Robson; Vittoria Vergani; Thomas Benkert; Maria Giovanna Trivieri; Nicolas A Karakatsanis; Ronan Abgral; Marc R Dweck; Pedro R Moreno; Jason C Kovacic; Kai Tobias Block; Zahi A Fayad Journal: J Nucl Cardiol Date: 2020-01-02 Impact factor: 3.872
Authors: Ana M Franceschi; Valentino Abballe; Roy A Raad; Aaron Nelson; Kimberly Jackson; James Babb; Thomas Vahle; Matthias Fenchel; Yiqiang Zhan; Gerardo Hermosillo Valadez; Timothy M Shepherd; Kent P Friedman Journal: World J Nucl Med Date: 2018 Jul-Sep